BMRANasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends May 31
BIOMERICA INC
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 15, 2026
$1.76−0.09 (-4.86%)
Close on Oct 19, 2026
- Market cap
- $5.80M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Biomerica's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Proxy statement | DEF 14A | Oct 16, 2026 | Oct 16, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Aug 31, 2026 | Oct 15, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 9, 2026 | Oct 15, 2026 | SEC EDGAR |
| Annual report, amended | 10-K/A | May 31, 2026 | Sep 28, 2026 | SEC EDGAR |
| Annual report | 10-K | May 31, 2026 | Aug 31, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 20, 2026 | Aug 26, 2026 | SEC EDGAR |
| Current report | 8-K | May 29, 2026 | Jun 4, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Feb 28, 2026 | Apr 13, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Nov 30, 2025 | Jan 14, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 12, 2025 | Dec 16, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Dec 12, 2025 | Oct 20, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Aug 31, 2025 | Oct 14, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 7, 2025 | Oct 8, 2025 | SEC EDGAR |
| Annual report, amended | 10-K/A | May 31, 2025 | Sep 26, 2025 | SEC EDGAR |
| Annual report | 10-K | May 31, 2025 | Aug 29, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2025 | Jun 6, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 15, 2025 | Apr 16, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Feb 28, 2025 | Apr 14, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Nov 30, 2024 | Jan 14, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 13, 2024 | Dec 17, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2024 | Nov 6, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Aug 31, 2024 | Oct 15, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 30, 2024 | Sep 30, 2024 | SEC EDGAR |
| Annual report | 10-K | May 31, 2024 | Aug 28, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2024 | Jun 28, 2024 | SEC EDGAR |
| Current report | 8-K | May 7, 2024 | May 10, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Feb 29, 2024 | Apr 12, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Nov 30, 2023 | Jan 16, 2024 | SEC EDGAR |
| Current report | 8-K | Dec 7, 2023 | Dec 11, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Aug 31, 2023 | Oct 12, 2023 | SEC EDGAR |
| Proxy statement | DEF 14A | Sep 27, 2023 | Sep 27, 2023 | SEC EDGAR |
| Current report | 8-K | Sep 15, 2023 | Sep 19, 2023 | SEC EDGAR |
| Current report | 8-K | Aug 28, 2023 | Aug 28, 2023 | SEC EDGAR |
| Annual report | 10-K | May 31, 2023 | Aug 25, 2023 | SEC EDGAR |
| Current report | 8-K | Jul 24, 2023 | Jul 26, 2023 | SEC EDGAR |
| Current report | 8-K | Apr 25, 2023 | Apr 25, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Feb 28, 2023 | Apr 14, 2023 | SEC EDGAR |
| Current report | 8-K | Mar 3, 2023 | Mar 7, 2023 | SEC EDGAR |
| Current report | 8-K | Mar 1, 2023 | Mar 2, 2023 | SEC EDGAR |
| Current report | 8-K | Feb 7, 2023 | Feb 7, 2023 | SEC EDGAR |